Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

n-(n-nonyl)-deoxygalactonojirimycin

Known as: n-(n-nonyl)-deoxygalacto-nojirimycin 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Abstract The Sharpless asymmetric epoxidation of d -glucose-derived allyl alcohol 4 afforded α- and β-epoxides 5a and 5b in high… Expand
Highly Cited
2005
Highly Cited
2005
II3NeuAc-GgOse4Cer (GM1) gangliosidosis is an incurable lysosomal storage disease caused by a deficiency in acid β-galactosidase… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 4
2004
2004
Summarythe effect of N-methyl-1-deoxy-nojirimycin (NMDN; 1,5-dideoxy-1,5-imino-N-methyl-D-glucit) was studied with crude extracts… Expand
  • figure 1
  • figure 2
  • figure 3
1999
1999
Novel lipophilic and neutral glucose analogs, which are potentially useful for tumor imaging, have been developed. They are… Expand
Highly Cited
1996
Highly Cited
1996
The antimetastatic activity of ten compounds structurally related to nojirimycin A was examined using a pulmonary metastatic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1990
1990
 
1989
1989
Castanospermine-glucosides (CS-glcs) are new compounds which have been evaluated as glycohydrolase inhibitors in rats. 7-O-alpha… Expand
Highly Cited
1984
Highly Cited
1984
A new aminosugar named nojirimycin B (1) has been isolated as its bisulfite adduct from the culture broth of Streptomyces… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2